Tech Company Financing Transactions
Resalis Therapeutics Funding Round
On 1/4/2024, Resalis Therapeutics announced $11 million in Series A funding from Sunstone Life Science Ventures, Claris Ventures and private investors.
Transaction Overview
Company Name
Announced On
1/4/2024
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Series A
Investors
Sunstone Life Science Ventures (Lead Investor) (Claus Andersson)
Proceeds Purpose
The proceeds will be used to initiate and complete the first-in-human Phase 1 clinical trial and reach Phase 2 readiness for Resalis' lead program, RES-010, in obesity. RES-010 is a non-coding RNA-based compound designed to provide a disease-modifying approach in obesity with longer-lasting weight reduction and the ability to extend treatment durability in combination with approved therapeutics, such as GLP-1 receptor agonists.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Via Nizza 52
Turin, 10126
IT
Turin, 10126
IT
Phone
Undisclosed
Website
Email Address
Overview
Resalis Therapeutics' transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease. The company is applying its unique understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, into a safe and convenient treatment providing disease-modifying therapeutic impact including durable weight loss and reduction of hepatic steatosis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alessandro Toniolo
Browse more venture capital transactions:
Prev: 1/4/2024: Vigilant Ops venture capital transaction
Next: 1/4/2024: UrbanStems venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs